2,303 results on '"Leung, Donald Y.M."'
Search Results
2. Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study
3. Skin as the target for allergy prevention and treatment
4. Atopic Dermatitis Complicated by Recurrent Eczema Herpeticum Is Characterized by Multiple, Concurrent Epidermal Inflammatory Endotypes
5. Skin biomarkers predict the development of food allergy in early life
6. Air pollutants contribute to epithelial barrier dysfunction and allergic diseases
7. CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity
8. The impact of temperature on the skin barrier and atopic dermatitis
9. Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development
10. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
11. The SunBEAm birth cohort: Protocol design
12. Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry
13. Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin
14. Targeting Skin Barrier Function in Atopic Dermatitis
15. Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis
16. The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice
17. Physical influences on the skin barrier and pathogenesis of allergy
18. Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis
19. Epidermal differentiation complex genetic variation in atopic dermatitis and peanut allergy
20. Endotypes of atopic dermatitis and food allergy
21. List Of Contributors
22. Atopic and Contact Dermatitis
23. Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
24. Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections
25. Transient receptor potential vanilloid 1 plays a major role in low temperature–mediated skin barrier dysfunction
26. Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts
27. Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors
28. Multiethnic genome-wide and HLA association study of total serum IgE level
29. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
30. SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca2+ Mobilization in Primary Human Keratinocytes
31. Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy
32. Why are immune adverse events so common with checkpoint inhibitor therapy?
33. Immune-related cutaneous adverse events due to checkpoint inhibitors
34. The Transcription Factor p63 Is a Direct Effector of IL-4– and IL-13–Mediated Repression of Keratinocyte Differentiation
35. Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research
36. Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin
37. Unique skin abnormality in patients with peanut allergy but no atopic dermatitis
38. Contributors
39. Atopic Dermatitis and Allergic Contact Dermatitis
40. Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A US Expert Consensus.
41. Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis
42. Immune checkpoint inhibitor–related dermatologic adverse events
43. Early epitope-specific IgE antibodies are predictive of childhood peanut allergy
44. Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy
45. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
46. Cutaneous barrier dysfunction in allergic diseases
47. Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children
48. Summary of the Keystone Symposium “Origins of allergic disease: Microbial, epithelial and immune interactions,” March 24-27, Tahoe City, California
49. Best of 2019
50. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.